Created at Source Raw Value Validated value
June 25, 2024, noon usa

inclusion criteria: * provision of signed and dated informed consent form * stated willingness to comply with all study procedures and availability for the duration of the study * at least 18 years of age * clinical diagnosis of dysautonomia following an acute covid-19 infection at least 3 months prior. see below for criteria: * clinical diagnosis of autonomic dysfunction as evaluated by a qualified healthcare provider * 2 or more if the following clinical assessment findings * symptomatic exacerbation during active stand test * tachycardia on active stand test * tachycardia on orthostatic vitals assessment * hypotension on orthostatic vitals assessment * hypertension in orthostatic vitals assessment * symptom exacerbation on orthostatic vitals assessment * english speaking

inclusion criteria: * provision of signed and dated informed consent form * stated willingness to comply with all study procedures and availability for the duration of the study * at least 18 years of age * clinical diagnosis of dysautonomia following an acute covid-19 infection at least 3 months prior. see below for criteria: * clinical diagnosis of autonomic dysfunction as evaluated by a qualified healthcare provider * 2 or more if the following clinical assessment findings * symptomatic exacerbation during active stand test * tachycardia on active stand test * tachycardia on orthostatic vitals assessment * hypotension on orthostatic vitals assessment * hypertension in orthostatic vitals assessment * symptom exacerbation on orthostatic vitals assessment * english speaking

Dec. 1, 2022, 4 p.m. usa

inclusion criteria: provision of signed and dated informed consent form stated willingness to comply with all study procedures and availability for the duration of the study at least 18 years of age clinical diagnosis of dysautonomia following an acute covid-19 infection at least 3 months prior. see below for criteria: clinical diagnosis of autonomic dysfunction as evaluated by a qualified healthcare provider 2 or more if the following clinical assessment findings symptomatic exacerbation during active stand test tachycardia on active stand test tachycardia on orthostatic vitals assessment hypotension on orthostatic vitals assessment hypertension in orthostatic vitals assessment symptom exacerbation on orthostatic vitals assessment english speaking

inclusion criteria: provision of signed and dated informed consent form stated willingness to comply with all study procedures and availability for the duration of the study at least 18 years of age clinical diagnosis of dysautonomia following an acute covid-19 infection at least 3 months prior. see below for criteria: clinical diagnosis of autonomic dysfunction as evaluated by a qualified healthcare provider 2 or more if the following clinical assessment findings symptomatic exacerbation during active stand test tachycardia on active stand test tachycardia on orthostatic vitals assessment hypotension on orthostatic vitals assessment hypertension in orthostatic vitals assessment symptom exacerbation on orthostatic vitals assessment english speaking